Topiramate Tablet, Film Coated
Product Images NDC 60760-752
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 60760-752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This text shows cumulative rates for time to the first seizure for two groups treated with different dosages of Topiramate - 50 mg/day (N=234) and 400 mg/day (N=236). The analysis implies that the group taking 400 mg/day had a significantly lower seizure rate as indicated by the p-value of 0.00002. The data is presented over a time span represented in days ranging from 0 to 400.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
752-60 (Topiramate 60760 752 60)
This text appears to be a label or information sheet for a medication called Topiramate. The medication comes in tablet form with a strength of 25mg. It is manufactured by Unichem Laboratories in Ghaziabad, India. The quantity provided is 60 tablets, and the National Drug Code (NDC) is 60760-752-60. The lot number is 2777272 and the expiration date is 7772. It is recommended to use the medication as directed by a prescription. Topiramate is listed multiple times on the label along with corresponding details. The label also includes information about storage and usage instructions.*
Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.